| Literature DB >> 30036390 |
Yahui Zhang1, Lin Qi1, Lisheng Xu1,2, Xingguo Sun3, Wenyan Liu1, Shuran Zhou1, Frans van de Vosse1,4, Stephen E Greenwald5.
Abstract
BACKGROUND: Exercise is accepted as an important contribution to the rehabilitation of patients with cardiovascular disease (CVD). This study aims to better understand the possible causes for lack of consensus and reviews the effects of three exercise modalities (aerobic, resistance and combined exercise) on central hemodynamics, arterial stiffness and cardiac function for better rehabilitation strategies in CVD.Entities:
Mesh:
Year: 2018 PMID: 30036390 PMCID: PMC6056055 DOI: 10.1371/journal.pone.0200829
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart of the study selection procedure.
Characteristics of the included studies.
| Article, year | Country | Participant Characteristic, Sample Size | Disease | Intervention/comparison groups | Duration of trial period | Outcomes | Time point |
|---|---|---|---|---|---|---|---|
| Acar (2015) [ | Turkey | 54 subjects (G1 = 27, G2 = 27). Mean age: G1 = 57 years, G2 = 57 years | Acute myocardial infarction | G1: Cardiac rehabilitation exercise program G2: No intervention | Three to four times weekly for 3 months | LVEF | 3 months |
| Aksoy (2015) [ | Turkey | 38 subjects (G1 = 19, G2 = 19). Mean age(SD): G1 = 63.7 years (8.8), G2 = 57.5 years (11.2) | Heart failure | G1: Intermittent aerobic exercise G2: No intervention | Three times a week for 10 weeks | LVEF | 10 weeks |
| Aksoy (2015) [ | Turkey | 38 subjects (G1 = 19, G2 = 19). Mean age(SD): G1 = 59.6 years (6.9), G2 = 57.5 years (11.2) | Heart failure | G1: Moderate-intensity continuous aerobic exercise G2: No intervention | Three times a week for 10 weeks | LVEF | 10 weeks |
| Andersen (2014) [ | UK | 33 subjects (G1 = 21, G2 = 22). Mean age(SD): G1 = 45.8 years (7.2), G2 = 46.9 years (7.6) | Hypertensive men | G1: Football exercise G2: No intervention | Two times per week for 3 months | LVEF | 3 months |
| Andersen (2014) [ | UK | 33 subjects (G1 = 21, G2 = 22). Mean age(SD): G1 = 45.8 years (7.2), G2 = 46.9 years (7.6) | Hypertensive men | G1: Football exercise G2: No intervention | Two times per week for 6 months | LVEF | 6 months |
| Beck (2013) [ | USA | 28 subjects (G1 = 13, G2 = 15). Mean age(SD): G1 = 20.1 years (3.2), G2 = 21.6 years (3.1) | Prehypertensive subjects | G1: Endurance exercise G2: No intervention | Three days per week for 8 weeks | ASP, ADP, AIx, cf-PWV | 8 weeks |
| Beer (2008) [ | UK | 24 subjects (G1 = 12, G2 = 12). Mean age(SD): G1 = 52.8 years (12), G2 = 58.2 years (16) | Patients with dilated cardiomyopathy | G1: Exercise training G2: No intervention | Five sessions/week for 2 months | LVEF | 2 months |
| Beer (2008) [ | UK | 24 subjects (G1 = 12, G2 = 12). Mean age(SD): G1 = 52.8 years (12), G2 = 58.2 years (16) | Patients with dilated cardiomyopathy | G1: Exercise training G2: No intervention | Five sessions/week for 8 months | LVEF | 8 months |
| Belardinelli (1995) [ | USA | 27 subjects (G1 = 18, G2 = 9). Mean age(SD): G1 = 56 years (7), G2 = 57 years (6) | Heart failure | G1: Exercise training G2: No intervention | Three times a week for 12 weeks | LVEF | 12 weeks |
| Blumenthal (2000) [ | USA | 78 subjects (G1 = 54, G2 = 24). Mean age(SD): G1 = 46.6 years (1.2), G2 = 47.2 years (1.8) | Mild hypertension | G1: Aerobic training G2: No intervention | Three to four times per week for 6 months | CO | 6 months |
| Brubaker (2009) [ | USA | 59 subjects (G1 = 30, G2 = 29). Mean age(SD): G1 = 70.4 years (5.3), G2 = 69.9 years (6.3) | Heart failure | G1: Aerobic exercise program G2: No intervention | Three times per week for 16 weeks | LVEF | 16 weeks |
| Donley (2014) [ | USA | 22 subjects (G1 = 11, G2 = 11). Mean age :G1 = 46 years, G2 = 44 years | Metabolic syndrome | G1: Aerobic exercise G2: No intervention | Three times a week for 8 weeks | ASP, AIx, cf-PWV | 8 weeks |
| Dubach (1997) [ | USA | 25 subjects (G1 = 12, G2 = 13). Mean age(SD): G1 = 56 years (5), G2 = 55 years (7) | Myocardial infarction | G1: Aerobic exercise G2: Usual clinical follow-up | 45 min periods/week for 8 weeks | CO, LVEF | 8 weeks |
| Dubach (1997) [ | USA | 25 subjects (G1 = 12, G2 = 13). Mean age(SD): G1 = 56 years (5), G2 = 55 years (7) | Myocardial infarction | G1: Aerobic exercise G2: Usual clinical follow-up | 45 min periods a week for 2 months | CO, LVEF | 2 months |
| Faulkner (2016) [ | UK | 47 subjects (G1 = 25, G2 = 22). Mean age(SD): G1 = 66 years (12), G2 = 68 years (10) | Stroke | G1: Aerobic exercise G2: Usual care | Twice weekly for 12 weeks | AIx, ASP | 12 weeks |
| Fu (2013) [ | Taiwan, China | 30 subjects (G1 = 15, G2 = 15). Mean age(SD): G1 = 67.5 years (6.97), G2 = 67.8 years (9.68) | Heart failure | G1: Aerobic interval training G2: General healthcare | Three days/week for 12 weeks | LVEF, CO | 12 weeks |
| Fu (2013) [ | Taiwan, China | 30 subjects (G1 = 15, G2 = 15). Mean age(SD): G1 = 66.3 years (8.13), G2 = 67.8 years (9.68) | Heart failure | G1: Moderate continuous training G2: General healthcare | Three days/week for 12 weeks | LVEF, CO | 12 weeks |
| Giallauria (2013) [ | Italy | 46 subjects (G1 = 25, G2 = 21). Mean age(SD): G1 = 54 years (7), G2 = 54 years (9) | Acute myocardial infarction | G1: Multi-comprehensive exercise intervention G2: General healthcare | Three times/week for 6 months | LVEF | 6 months |
| Giannuzzi (2003) [ | Italy | 90 subjects (G1 = 45, G2 = 45). Mean age(SD): G1 = 54 years (7), G2 = 54 years (9) | Chronic heart failure | G1: Moderate continuous training G2: Educational support | Three to five times a week for 6 months | LVEF | 6 months |
| Guimaraes (2010) [ | Brazil | 27 subjects (G1 = 16, G2 = 11). Mean age(SD): G1 = 50 years (8), G2 = 47 years (6) | Hypertension | G1: Continuous exercise training G2: Sedentary routine | Two 40-min sessions a week for 16 weeks | cf-PWV | 16 weeks |
| Guimaraes (2010) [ | Brazil | 27 subjects (G1 = 16, G2 = 11). Mean age(SD): G1 = 45 years (9), G2 = 47 years (6) | Hypertension | G1: Interval exercise training G2: Sedentary routine | Two 40-min sessions a week for 16 weeks | cf-PWV | 16 weeks |
| Hambrecht (2000) [ | Germany | 73 subjects (G1 = 36, G2 = 37). Mean age(SD): G1 = 54 years (9), G2 = 55 years (8) | Chronic heart failure | G1: Ergometer exercise training G2: No intervention | Four to six times per day in 2 week for 6 months | CO, LVEF | 6 months |
| Huang (2014) [ | Taiwan, China | 66 subjects (G1 = 33, G2 = 33). Mean age(SD): G1 = 60 years (17.22), G2 = 56 years (22.96) | Heart failure | G1: Modified high-intensity interval training G2: Usual healthcare | Three days/week for 8 weeks | CO | 8 weeks |
| Iellamo (2000) [ | Italy | 86 subjects (G1 = 45, G2 = 41). Mean age(SD): G1 = 59.4 years (7.8), G2 = 58.5 years (7.3) | Coronary artery disease | G1:Cardiac rehabilitation G2: Usual healthcare | 2–4 times for 4 weeks | ASP, ADP | 4 weeks |
| Kitzman (2013) [ | Canada | 63 subjects (G1 = 32, G2 = 31). Mean age(SD): G1 = 70 years (7), G2 = 70 years (7) | Heart failure | G1: Endurance exercise training G2: Attention control | Three times per week for 16 weeks | LVEF | 16 weeks |
| Krustrup (2013) [ | Denmark | 33 subjects (G1 = 22, G2 = 11). Mean age :G1 = 46 years, G2 = 46 years | Hypertensive men | G1: Soccer training G2: Doctor advice | Two sessions per week for 3 months | AIx | 3 months |
| Krustrup (2013) [ | Denmark | 33 subjects (G1 = 22, G2 = 11). Mean age :G1 = 46 years, G2 = 46 years | Hypertensive men | G1: Soccer training G2: Doctor advice | Two sessions per week for 6 months | AIx | 6 months |
| Madden (2013) [ | Canada | 52 subjects (G1 = 26, G2 = 26). Mean age(SD): G1 = 68.5 years (4.6), G2 = 70 years (4.1) | Hypertension | G1: Vigorous aerobic exercise G2: No intervention | Three times per week for 3 months | cf-PWV | 3 months |
| Madden (2013) [ | Canada | 52 subjects (G1 = 26, G2 = 26). Mean age(SD): G1 = 68.5 years (4.6), G2 = 70 years (4.1) | Hypertension | G1: Vigorous aerobic exercise G2: No intervention | Three times per week for 6 months | cf-PWV | 6 months |
| Molmen-Hansen (2012) [ | Norway | 57 subjects (G1 = 28, G2 = 29). Mean age(SD): G1 = 53.6 years (6.5), G2 = 51.3 years (9.2) | Hypertensive patients | G1: Moderate intensity continuous training G2: Standard care | Three times per week for 12 weeks | LVEF, CO | 12 weeks |
| Nualnim (2012) [ | USA | 43 subjects (G1 = 24, G2 = 19). Mean age(SD): G1 = 58 years (9.8), G2 = 61 years (8.7) | Hypertension | G1: Swimming training G2: Attention control | Three to four days a week for 12 weeks | ASP, APP, AIx, CO, cf-PWV | 12 weeks |
| Oliveira (2015) [ | Portugal | 86 subjects (G1 = 44, G2 = 42). Mean age: G1 = 55 years, G2 = 58.5 years | Myocardial infarction | G1: Exercise-based cardiac rehabilitation program G2: No intervention | Three sessions a week for 8 weeks | ASP, ADP, AIx, cf-PWV | 8 weeks |
| Parnell (2002) [ | Australia | 21 subjects (G1 = 11, G2 = 10). Mean age(SD): G1 = 57 years (15), G2 = 53 years (11) | Congestive heart failure | G1: Aerobic exercise training G2: Usual lifestyle | Once a day on 5–7 days per week for 8 weeks | ASP, ADP, AIx, cf-PWV | 8 weeks |
| Seals (2001) [ | USA | 35 subjects (G1 = 18, G2 = 17). Mean age(SD): G1 = 62 years (9), G2 = 65 years (10) | Elevated systolic pressure | G1: Walking G2: Sodium restriction | Five days a week for the 3 months | ASP, ADP, AIx, cf-PWV | 3 months |
| Su (2011) [ | Taiwan, China | 29 subjects (G1 = 17, G2 = 12). Mean age(SD): G1 = 52 years (9), G2 = 52 years (8) | Chronic myocardial infarction | G1: Training program G2: No intervention | 3 months | LVEF | 3 months |
| Tang (2013) [ | Canada | 50 subjects (G1 = 25, G2 = 25). Mean age(SD): G1 = 65.9 years (6.4), G2 = 66.9 years (7.8) | Stroke | G1: High-intensity aerobic exercise G2: Non-aerobic Balance/Flexibility | Three times a week for 6 months | LVEF | 6 months |
| Westhoff (2008) [ | Germany | 24 subjects (G1 = 12, G2 = 12). Mean age(SD): G1 = 66.1 years (4), G2 = 68.4 years (9.7) | Hypertension | G1: Upper-limb cycling aerobic exercise training G2: No intervention | Three times a week for 12 weeks | AIx | 12 weeks |
| Adamopoulos (2014) [ | Belgium | 33 subjects (G1 = 21, G2 = 22). Mean age(SD): G1 = 57.8 years (11.7), G2 = 58.3 years (13.2) | Chronic heart failure | G1: Muscle training and aerobic exercise G2: Aerobic exercise | Three times a week for 12 weeks | LVEF | 12 weeks |
| Beck (2013) [ | USA | 30 subjects (G1 = 15, G2 = 15). Mean age (SD): G1 = 21.1 years (2.3), G2 = 21.6 years (3.1) | Prehypertensive subjects | G1: Resistance exercise G2: No intervention | Three days per week for 8 weeks | ASP, ADP, AIx, cf-PWV | 8 weeks |
| Bilinska (2010) [ | Poland | 120 subjects (G1 = 60, G2 = 60). Mean age(SD): G1 = 54.1 years (5.8), G2 = 53.9 years (5) | Patients after coronary artery bypass grafting | G1: Static training G2: No intervention | Three times a week for 6 weeks | CO | 6 weeks |
| Blumenthal (2000) [ | USA | 78 subjects (G1 = 54, G2 = 24). Mean age(SD): G1 = 46.6 years (1.2), G2 = 47.2 years (1.8) | Mild hypertension | G1: Strength and flexibility training G2: No intervention | Three supervised exercise sessions every week for 16 weeks | CO | 16 weeks |
| Figueroa (2013) [ | USA | 25 subjects (G1 = 13, G2 = 12). Mean age(SD): G1 = 56.4 years (2.53), G2 = 55.5 years (3.46) | Hypertension | G1: Whole-body vibration exercise training G2: No intervention | Three supervised training sessions per week for 12 weeks | cf-PWV | 12 weeks |
| Heffernan (2013) [ | USA | 21 subjects (G1 = 11, G2 = 10). Mean age(SD): G1 = 60 years (2), G2 = 63 years (3) | Hypertension | G1: Resistance exercise training G2: Inactive control group | Three days a week for 12 weeks | ASP, ADP, AIx | 12 weeks |
| Acanfora (2016) [ | Italy | 40 subjects (G1 = 20, G2 = 20). Mean age(SD): G1 = 71 years (4), G2 = 71 years (3) | Chronic heart failure | G1: Exercise training G2: No intervention | Six times a week for 4 weeks | LVEF | 4 weeks |
| Acanfora (2016) [ | Italy | 32 subjects (G1 = 16, G2 = 16). Mean age(SD): G1 = 54 years (4), G2 = 53 years (3) | Chronic heart failure | G1: Exercise training G2: No intervention | Six times a week for 4 weeks | LVEF | 4 weeks |
| Chrysohoou (2015) [ | Greece | 72 subjects (G1 = 33, G2 = 39). Mean age(SD): G1 = 63 years (9), G2 = 56 years (11) | Chronic heart failure | G1: Combined aerobic exercise and strength exercise G2: No intervention | Three days a week for 12 consecutive weeks | LVEF, AIx, cf-PWV | 12 weeks |
| Ehlken (2016) [ | Switzerland | 87 subjects (G1 = 46, G2 = 41). Mean age(SD): G1 = 55 years (15), G2 = 57 years (15) | Arterial hypertension | G1: Exercise training G2: No intervention | Five days a week for the following 12 weeks | CO | 12 weeks |
| Lee (2015) [ | South Korea | 26 subjects (G1 = 14, G2 = 12). Mean age(SD): G1 = 64 years (7.4), G2 = 63 years (5.45) | Chronic post stroke hemiparesis | G1: Combined aerobic and resistance exercise G2: Standard care | Three times a week for 16 weeks | ASP, ADP, cf-PWV | 16 weeks |
| Molmen-Hansen (2012) [ | Norway | 60 subjects (G1 = 31, G2 = 29). Mean age(SD): G1 = 52.5 years (7.4), G2 = 51.3 years (9.2) | Hypertensive patients | G1: Combined aerobic and resistance exercise G2: Standard care | Three times per week for 12 weeks | LVEF, CO | 12 weeks |
| Stewart (2005) [ | USA | 104 subjects (G1 = 51, G2 = 53). Mean age: G1 = 63 years, G2 = 64.1 years | Hypertension | G1: Combined aerobic and resistance training G2: Usual care | Three days a week for 26 weeks | cf-PWV | 6 months |
Abbreviations: ASP, aortic systolic pressure; ADP, aortic diastolic pressure; CO, cardiac output; LVEF, left ventricle ejection fraction; AIx, augmentation index; cf-PWV, carotid-femoral pulse wave velocity.
Risks of bias among the selected articles.
| Article, year | Eligibility criteria | Random allocation | Concealed allocation | Baseline comparability | Blind subjects | Blind therapists | Blind assessors | Adequate follow-up | Intention to treat analysis | Between- group comparisons | Point estimates and variability |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Acanfora (2016) [ | YES | YES | NO | YES | NO | NO | NO | NO | NO | YES | YES |
| Acar (2015) [ | YES | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
| Adamopoulos (2014) [ | YES | YES | NO | YES | NO | NO | NO | NO | NO | YES | YES |
| Aksoy (2015) [ | YES | YES | NO | YES | NO | NO | NO | NO | NO | YES | YES |
| Andersen (2014) [ | NO | YES | YES | YES | NO | NO | NO | YES | YES | YES | YES |
| Beck (2013) [ | YES | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
| Beer (2008) [ | NO | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Belardinell (1995) [ | YES | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
| Bilinska (2010) [ | YES | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
| Blumenthal (2000) [ | YES | YES | NO | YES | NO | NO | NO | NO | YES | YES | NO |
| Brubaker (2009) [ | NO | YES | NO | YES | NO | NO | YES | NO | NO | YES | YES |
| Chrysohoou (2015) [ | YES | YES | NO | YES | NO | NO | NO | NO | YES | YES | YES |
| Donley (2014) [ | NO | YES | NO | NO | NO | NO | NO | YES | NO | YES | YES |
| Dubach (1997) [ | NO | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
| Ehlken (2016) [ | NO | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Faulkner (2016) [ | YES | YES | NO | YES | NO | NO | NO | YES | YES | YES | YES |
| Figueroa (2013) [ | YES | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Fu (2013) [ | YES | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
| Giallauria (2013) [ | YES | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Giannuzzi (2003) [ | YES | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Guimaraes (2010) [ | YES | YES | NO | YES | NO | NO | YES | NO | NO | NO | YES |
| Hambrecht (2000) [ | YES | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Heffernan (2013) [ | NO | YES | NO | YES | NO | NO | NO | NO | NO | YES | NO |
| Huang (2014) [ | YES | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
| Iellamo (2000) [ | YES | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Kitzman (2013) [ | YES | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Krustrup (2013) [ | NO | YES | NO | YES | NO | NO | NO | YES | YES | YES | YES |
| Lee (2015) [ | YES | YES | YES | YES | NO | NO | YES | YES | NO | YES | YES |
| Madden (2013) [ | YES | YES | YES | YES | NO | NO | YES | YES | YES | YES | YES |
| Molmen-Hansen (2012) [ | YES | YES | NO | YES | NO | NO | NO | NO | NO | YES | YES |
| Nualnim (2012) [ | YES | YES | NO | YES | NO | NO | YES | YES | YES | YES | YES |
| Oliveira (2015) [ | YES | YES | NO | YES | NO | NO | YES | YES | YES | YES | YES |
| Parnell (2002) [ | YES | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Seals (2001) [ | NO | YES | NO | YES | NO | NO | YES | YES | NO | YES | YES |
| Stewart (2005) [ | YES | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
| Su (2011) [ | NO | YES | NO | YES | NO | NO | NO | NO | NO | NO | YES |
| Tang (2013) [ | NO | YES | YES | YES | NO | NO | YES | YES | YES | YES | YES |
| Westhoff (2008) [ | YES | YES | NO | YES | NO | NO | NO | YES | NO | YES | YES |
Summary of results.
| Outcome | Trials | Participant | Statistical Method | Effect Estimate | Heterogeneity | P Value |
|---|---|---|---|---|---|---|
| Central hemodynamics | ||||||
| ASP | 7 [ | 282 | MD (IV, fixed, 95% CI) | -5.87 [-8.85, -2.88] | 0.12 | 0.0001 |
| ADP | 4 [ | 221 | MD (IV, fixed, 95% CI) | 0.06 [-2.19, 2.31] | 0.21 | 0.96 |
| AIx | 10 [ | 372 | MD (IV, random, 95% CI) | -2.62 [-6.51, 1.27] | <0.00001 | 0.19 |
| Arterial stiffness | ||||||
| Cf-PWV | 8 [ | 330 | MD (IV, fixed, 95% CI) | -0.42 [-0.83, -0.01] | 0.95 | 0.04 |
| Cardiac function | ||||||
| CO | 7 [ | 372 | MD (IV, fixed, 95% CI) | 0.36 [0.08 to 0.64] | 0.43 | 0.01 |
| LVEF | 19 [ | 843 | MD (IV, fixed, 95% CI) | 3.02 [2.11, 3.93] | 0.01 | <0.00001 |
| Central hemodynamics | ||||||
| ASP | 2 [ | 51 | MD (IV, fixed, 95% CI) | -7.62 [-10.69 to -4.54] | 0.76 | <0.00001 |
| ADP | 2 [ | 51 | MD (IV, fixed, 95% CI) | -4 [-5.63, -2.37] | 1 | <0.00001 |
| AIx | 2 [ | 51 | MD (IV, random, 95% CI) | 0.42 [-4.55, 5.38] | 0.003 | 0.87 |
| Arterial stiffness | ||||||
| Cf-PWV | 2 [ | 55 | MD (IV, fixed, 95% CI) | -0.26 [-0.72, 0.20] | 0.18 | 0.27 |
| Cardiac function | ||||||
| CO | 1 [ | 78 | MD (IV, fixed, 95% CI) | -0.02 [-0.6 to 0.56] | 0.95 | |
| LVEF | 1 [ | 43 | MD (IV, fixed, 95% CI) | 2 [-3.26 to 7.26] | 0.46 | |
| Central hemodynamics | ||||||
| ASP | 1 [ | 26 | MD (IV, fixed, 95% CI) | -3.82 [-13.07 to 5.43] | 0.42 | |
| ADP | 1 [ | 26 | MD (IV, fixed, 95% CI) | -4.2 [-11.49, 3.09] | 0.26 | |
| AIx | 1 [ | 72 | MD (IV, random, 95% CI) | 7.60 [3.75, 11.45] | 0.0001 | |
| Arterial stiffness | ||||||
| Cf-PWV | 3 [ | 202 | MD (IV, fixed, 95% CI) | -1.15 [-1.95, -0.36] | 0.64 | 0.004 |
| Cardiac function | ||||||
| CO | 1 [ | 60 | MD (IV, fixed, 95% CI) | 0.9 [-0.39 to 1.41] | 0.0006 | |
| LVEF | 3 [ | 140 | MD (IV, fixed, 95% CI) | 0.79 [-1.18 to 2.77] | 0.54 | 0.43 |
Abbreviations: ASP, aortic systolic pressure; ADP, aortic diastolic pressure; cf-PWV, carotid-femoral pulse wave velocity; CO, cardiac output; LVEF, left ventricle ejection fraction.
Fig 2Forest plot of the change in aortic systolic pressure (ASP) in the exercise and control groups.
Subgroups correspond to the exercise modalities. Squares represent the MD for each trial, and diamonds represent the pooled MD in ASP across trials. SD = standard deviation; IV = inverse variance; 95% CI = 95% confidence intervals.
Subgroup analyses and meta-regression of effect of aerobic exercise on the central hemodynamics, arterial stiffness and cardiac function according to age, disease, exercise duration and gender.
| Variable | Trials (No.) | WMD(95%CI) | p and p value |
|---|---|---|---|
| < = 50 years | 3(71) | -6.10 [-10.80, -1.40] | 0.01 |
| >50 years | 4(211) | -5.71 [-9.57, -1.85] | 0.004 |
| hypertension | 2(71) | -7.74 [-12.35, -3.12] | 0.001 |
| heart disease | 4(164) | -4.20 [-8.29, -0.11] | 0.04 |
| stroke | 1(47) | -8.00 [-21.34, 5.34] | 0.24 |
| 8 weeks | 4(171) | -6.03 [-9.34, -2.72] | 0.0004 |
| 12 weeks | 3(111) | -5.15 [-12.06, 1.75] | 0.14 |
| Women | 1(35) | -10.00 [-15.83, -4.17] | 0.0008 |
| trial with men and women | 6(247) | -4.40 [-7.87, -0.93] | 0.01 |
| < = 50 years | 2(49) | -2.83 [-6.89, 1.22] | 0.17 |
| >50 years | 2(165) | 1.42 [-1.37, 4.20] | 0.32 |
| hypertension | 1(28) | -4.00 [-9.19, 1.19] | 0.13 |
| heart disease | 3(186) | 1.04 [-1.52, 3.60] | 0.43 |
| 4 weeks | 1(86) | 3.30 [-1.15, 7.75] | 0.15 |
| 8 weeks | 2(107) | -1.15 [-4.10, 1.79] | 0.44 |
| 12 weeks | 1(21) | -1.00 [-7.50, 5.50] | 0.76 |
| Men | 1(86) | 3.30 [-1.15, 7.75] | 0.15 |
| trial with men and women | 3(128) | -1.13 [-3.81, 1.55] | 0.41 |
| < = 50 years | 1(78) | -0.02 [-0.60, 0.56] | 0.95 |
| >50 years | 6(294) | 0.48 [0.16, 0.80] | 0.003 |
| hypertension | 3(178) | 0.29 [-0.10, 0.68] | 0.14 |
| heart failure | 4(194) | 0.44 [0.04, 0.84] | 0.03 |
| 8 weeks | 3(91) | 0.20 [-0.40, 0.80] | 0.51 |
| 12 weeks | 3(130) | 0.59 [0.10, 1.08] | 0.02 |
| 24 weeks | 2(151) | 0.28 [-0.14, 0.70] | 0.19 |
| Men | 2(98) | 0.51 [-0.02, 1.04] | 0.06 |
| trial with men and women | 5(274) | 0.30 [-0.03, 0.64] | 0.07 |
| < = 50 years | 4(97) | -0.46 [-1.23, 0.31] | 0.24 |
| >50 years | 4(233) | -0.40 [-0.89, 0.08] | 0.1 |
| hypertension | 5(201) | -0.43 [-0.93, 0.08] | 0.1 |
| heart disease | 3(129) | -0.40 [-1.10, 0.30] | 0.26 |
| 8 weeks | 2(108) | -0.49 [-1.22, 0.24] | 0.19 |
| 12 weeks | 3(116) | -0.30 [-0.88, 0.28] | 0.31 |
| > = 16weeks | 3(106) | -0.61 [-1.54, 0.32] | 0.2 |
| Men | 2(98) | 0.51 [-0.02, 1.04] | 0.06 |
| trial with men and women | 5(274) | 0.30 [-0.03, 0.64] | 0.07 |
| 0.981 | |||
| 40–50 years | 3(88) | -8.13 [-14.31, -1.95] | 0.01 |
| 50–60 years | 4(172) | -2.57 [-7.18, 2.03] | 0.27 |
| >60 years | 3(106) | 1.10 [-7.20, 9.40] | 0.8 |
| 0.206 | |||
| hypertension | 6(196) | -3.60 [-9.04, 1.85] | 0.2 |
| heart disease | 4(151) | -0.13 [-3.17, 2.90] | 0.93 |
| Stroke | 1(47) | -28.00 [-58.95, 2.95] | 0.08 |
| 0.133 | |||
| 8 weeks | 5(179) | -0.03 [-1.94, 1.88] | 0.97 |
| 12 weeks | 5(182) | -4.60 [-13.28, 4.07] | 0.3 |
| 24 weeks | 1(33) | -12.00 [-19.92, -4.08] | 0.003 |
| 0.703 | |||
| Men | 2(66) | -10.70 [-15.40, -6.01] | <0.00001 |
| Women | 1(35) | 6.00 [3.35, 8.65] | <0.00001 |
| trial with men and women | 6(271) | -1.11 [-3.78, 1.56] | 0.42 |
| 0.000 | |||
| < = 50 years | 2(76) | 7.45 [4.44, 10.47] | <0.00001 |
| >50 years | 17(767) | 2.58 [1.62, 3.53] | <0.00001 |
| 0.954 | |||
| hypertension | 3(133) | 7.47 [5.10, 9.84] | <0.00001 |
| heart failure | 9(458) | 2.25 [1.10, 3.41] | 0.0001 |
| other heart disease | 6(202) | 4.78 [2.01, 7.55] | 0.0007 |
| Stroke | 1(50) | 0.00 [-2.62, 2.62] | 1 |
| 0.918 | |||
| <12 weeks | 4(135) | 1.16 [-1.45, 3.78] | 0.38 |
| 12–16 weeks | 9(287) | 3.40 [1.89, 4.91] | <0.0001 |
| > = 24 weeks | 6(321) | 3.19 [1.93, 4.46] | <0.00001 |
| 0.276 | |||
| Men | 5(203) | 4.91 [2.69, 7.13] | <0.0001 |
| trial with men and women | 14(640) | 2.64 [1.65, 3.64] | <0.00001 |
p value for the meta-regression analysis between subgroups
p value for subgroup analysis between two group
ASP, aortic systolic pressure; ADP, aortic diastolic pressure; cf-PWV, carotid-femoral pulse wave velocity; CO, cardiac output; LVEF, left ventricle ejection fraction, WMD, weighted mean difference.
Fig 3Forest plot of the change in aortic diastolic pressure (ADP) in the exercise and control groups.
Subgroups correspond to the exercise modalities. Squares represent the MD for each trial, and diamonds represent the pooled MD in ADP across trials. SD = standard deviation; IV = inverse variance; 95% CI = 95% confidence intervals.
Fig 4Forest plot of the change in central augmentation index (AIx) in the exercise and control groups.
Subgroups correspond to the exercise modalities. Squares represent the MD for each trial, and diamonds represent the pooled MD in AIx across trials. SD = standard deviation; IV = inverse variance; 95% CI = 95% confidence intervals.
Fig 5Forest plot of the change in carotid-femoral pulse wave velocity (cf-PWV) in the exercise and control groups.
Subgroups correspond to the exercise modalities. Squares represent the MD for each trial, and diamonds represent the pooled MD in cf-PWV across trials. SD = standard deviation; IV = inverse variance; 95% CI = 95% confidence intervals.
Fig 6Forest plot of the change in cardiac output (CO) in the exercise and control groups.
Subgroups correspond to the exercise modalities. Squares represent the MD for each trial, and diamonds represent the pooled MD in CO across trials. SD = standard deviation; IV = inverse variance; 95% CI = 95% confidence intervals.
Fig 7Forest plot of the change in left ventricular ejection fraction (LVEF) in the exercise and control groups.
Subgroups correspond to the exercise modalities. Squares represent the MD for each trial, and diamonds represent the pooled MD in LVEF across trials. SD = standard deviation; IV = inverse variance; 95% CI = 95% confidence intervals.
Fig 8Meta-regression for exploring heterogeneity in LVEF.
(A) The association between mean difference of left ventricular ejection fraction (LVEF) and different age groups with CVD. (B) The association between mean difference of left ventricular ejection fraction (LVEF) and aerobic exercise intervention of different exercise durations. (The shaded areas represent the range of confidence interval; size of the circles indicates sample size).